Online Program

Implications for public health under the HIPAA omnibus final rule

Tuesday, November 5, 2013

Jennifer Bernstein, JD, MPH, Network for Public Health Law, Mid-States Region, University of Michigan School of Public Health, Ann Arbor, MI
The U.S. Department of Health and Human Services released the Health Information Portability and Accountability Act (HIPAA) Omnibus Final Rule on January 17, 2013. This final rule implements modifications required by the Genetic Information Nondiscrimination Act (GINA), as well as most of the Privacy, Security, and Enforcement provisions of the Health Information Technology for Economic and Clinical Health Act (HITECH Act). These changes are aimed at enhancing a patient's privacy protections, providing individuals new rights to their health information and strengthening the government's ability to enforce the law. This session will discuss the most important changes to HIPAA under this rule, including changes affecting hybrid entities. This session will then discuss the implications of these changes for public health agencies, practitioners and researchers.

Learning Areas:

Administration, management, leadership
Ethics, professional and legal requirements
Public health administration or related administration
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Identify the major changes for public health under the HIPAA Omnibus Final Rule. Assess the implications for public health agencies, practitioners and researchers under the HIPAA Omnibus Final Rule changes.

Keyword(s): Health Law, Health Insurance

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a staff attorney for the Mid-States Region of the Network for Public Health Law with a JD/MPH dual degree. I provide technical legal assistance to and develop resources for public health attorneys, practitioners and policy makers on a wide range of public health law topics, including data sharing and privacy.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.